Ramipril recalls
Ramipril products have been recalled 4 times, most recently on 2 Sep 2026. The recalling company is usually Lupin Pharmaceuticals. The most common reason is manufacturing (cgmp) deviations.
Total recalls4since 2024
Last 12 months1reported
Class I00% of total
Ongoing1latest 2 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why ramipril is recalled
Companies
Product types
By year
Ongoing ramipril recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ramipril Capsules USP, 10 mg recalled by Hikma Pharmaceuticals USARamipril | Hikma Pharmaceuticals USA | Potency & Assay | Nationwide |
All ramipril recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ramipril Capsules USP, 10 mg recalled by Hikma Pharmaceuticals USARamipril | Hikma Pharmaceuticals USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Ramipril Capsules USP 5 mg, a) recalled by Lupin PharmaceuticalsRamipril | Lupin Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ramipril Capsules USP 5 mg, a) recalled by Lupin PharmaceuticalsRamipril | Lupin Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ramipril Capsules USP 10 mg, a) recalled by Lupin PharmaceuticalsRamipril | Lupin Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.